Company: NUTR
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001641172-25-012203
Chunk: 218

Company: NUSATRIP Inc
Filing Date: 2025-05-23
Form: S-1/A
Chunk 218
---
 obligation or liability, to the extent that it is not fully reflected in the financial statements.

NOTE 17 — SUBSEQUENT EVENTS

On April 7, 2025, the subsidiary in Indonesia issued additional 40,000 of common stocks at IDR100,000 per share to the existing shareholders with the holding percentage remain unchanged.

Save as disclosed above, the Company’s management has evaluated subsequent events up to the date of these consolidated financial statements were available to be issued, pursuant to the requirements of ASC 855 and has determined there are no material subsequent events to disclose.

| F-52 |

<div align='center'>NUSATRIP INCORPORATED

3,750,000 SHARES OFCOMMON STOCK

PROSPECTUS

[ ], 2025</div>

No dealer, salesperson or any other person is authorized to give any information or make any representations in connection with this Offering other than those contained in this prospectus and, if given or made, the information or representations must not be relied upon as having been authorized by us. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any security other than the securities offered by this prospectus, or an offer to sell or a solicitation of an offer to buy any securities by anyone in any jurisdiction in which the offer or solicitation is not authorized or is unlawful.

Until and including [*], 2025 (twenty-five (25) days after the date of this prospectus), all dealers that buy, sell or trade our Common Stock, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the obligation of dealers to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions.

The information in this preliminary prospectus is not complete and may be changed. These securities may not be sold until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.

<div align='center'>SUBJECT TO COMPLETION
PRELIMINARY PROSPECTUS DATED MAY 23, 2025

NUSATRIP INCORPORATED

1,066,668 Shares of Common Stock</div>

This prospectus relates to the resale of up to 1,066,668 shares of common stock, $0.0001 par